Most read article(s)

You have access
IgG4-related Disease With Destructive Nasal Bone Involvement Leading to Saddle Nose Deformity
Giorgos Loizidis, Mindy R. Rabinowitz and Madalina Tuluc

The Journal of Rheumatology July 1 2022, 49 (7) 748-749; DOI: https://doi.org/10.3899/jrheum.200621
Open Access
Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan
Masataka Kuwana, Naoko Wakasugi, Toshinori Furuya, Satoshi Uno and Takafumi Suda

The Journal of Rheumatology July 1 2022, 49 (7) 707-718; DOI: https://doi.org/10.3899/jrheum.210322
You have access
Spondyloarthritis Among Patients With Uveitis: Can We Improve Referral Pathways?
Lihi Eder

The Journal of Rheumatology July 1 2022, 49 (7) 659-660; DOI: https://doi.org/10.3899/jrheum.220263
You have access
Uveitis in Juvenile Psoriatic Arthritis: Still So Much To Learn
Kamiar Mireskandari

The Journal of Rheumatology July 1 2022, 49 (7) 661-662; DOI: https://doi.org/10.3899/jrheum.220163
You have access
Getting the Diagnosis Right: What’s in a Name?
Soumya Chatterjee

The Journal of Rheumatology July 1 2022, 49 (7) 853-854; DOI: https://doi.org/10.3899/jrheum.220017
Open Access
Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis
Philip J. Mease, Arthur Kavanaugh, Alexis Ogdie, Alvin F. Wells, Martin Bergman, Dafna D. Gladman, Sven Richter, Lichen Teng, Shauna Jardon and Josef S. Smolen

The Journal of Rheumatology July 1 2022, 49 (7) 694-699; DOI: https://doi.org/10.3899/jrheum.210906
Open Access
Effectiveness of 6-month Use of Secukinumab in Patients With Psoriatic Arthritis in the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
Philip J. Mease, Taylor Blachley, Blessing Dube, Robert R. McLean, Nina Kim, Peter Hur and Alexis Ogdie

The Journal of Rheumatology July 1 2022, 49 (7) 700-706; DOI: https://doi.org/10.3899/jrheum.211033
Open Access
Vasculitis: What Have We Learned in the Last 50 Years?
Simon Carette

The Journal of Rheumatology July 1 2022, 49 (7) 848-852; DOI: https://doi.org/10.3899/jrheum.220207
You have access
A Case of Scleromyxedema Development Following Intravesical Bacillus Calmette-Guérin Administration
Reşit Yildirim, Döndü Üsküdar Cansu and Cengiz Korkmaz

The Journal of Rheumatology July 1 2022, 49 (7) 858-859; DOI: https://doi.org/10.3899/jrheum.211010
You have access
Dr. Trefond et al reply: Giant Cell Arteritis After SARS-CoV-2 Vaccination—Coincidence or Trigger?
Ludovic Trefond, Agathe Sauret, Julien Stievenart, Louis Olagne, Benedicte Guelon, Perrine Smets, Olivier Aumaître and Marc André

The Journal of Rheumatology July 1 2022, 49 (7) 860; DOI: https://doi.org/10.3899/jrheum.211158.C1

Main menu

User menu

Search

Most read article(s)

Pages

Content

Resources

Subscribers

More